Jellyfish Collagen: A Biocompatible Collagen Source for 3D Scaffold Fabrication and Enhanced Chondrogenicity

Ahmed, Zara; Powell, Lydia; Matin, Navid; Mearns-Spragg, Andrew; Thornton, Catherine A.; Khan, Ilyas M.; Francis, Lewis

doi:10.3390/md19080405

Journal article 356 views 58 downloads

Jellyfish Collagen: A Biocompatible Collagen Source for 3D Scaffold Fabrication and Enhanced Chondrogenicity

Zara Ahmed, Lydia Powell

, Navid Matin, Andrew Mearns-Spragg

, Catherine A. Thornton, Ilyas M. Khan, Lewis Francis

Marine Drugs, Volume: 19, Issue: 8, Start page: 405

Swansea University Authors: Lydia Powell , Lewis Francis

PDF | Version of Record

© 2021 by the authors. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license
Download (3.1MB)

Check full text

DOI (Published version): 10.3390/md19080405

Abstract

Osteoarthritis (OA) is a multifactorial disease leading to degeneration of articular cartilage, causing morbidity in approximately 8.5 million of the UK population. As the dense extracellular matrix of articular cartilage is primarily composed of collagen, cartilage repair strategies have exploited...

Full description

Published in:	Marine Drugs
ISSN:	1660-3397
Published:	MDPI AG 2021
Online Access:	Check full text
URI:	https://cronfa.swan.ac.uk/Record/cronfa61611
Tags:	Add Tag No Tags, Be the first to tag this record!

first_indexed	2022-11-09T13:03:25Z
last_indexed	2023-01-13T19:22:28Z
id	cronfa61611
recordtype	SURis
fullrecord	<?xml version="1.0" encoding="utf-8"?><rfc1807 xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema"><bib-version>v2</bib-version><id>61611</id><entry>2022-10-20</entry><title>Jellyfish Collagen: A Biocompatible Collagen Source for 3D Scaffold Fabrication and Enhanced Chondrogenicity</title><swanseaauthors><author><sid>0e7e702952672bcbfdfd4974199202fb</sid><ORCID>0000-0002-8641-0160</ORCID><firstname>Lydia</firstname><surname>Powell</surname><name>Lydia Powell</name><active>true</active><ethesisStudent>false</ethesisStudent></author><author><sid>10f61f9c1248951c1a33f6a89498f37d</sid><ORCID>0000-0002-7803-7714</ORCID><firstname>Lewis</firstname><surname>Francis</surname><name>Lewis Francis</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2022-10-20</date><deptcode>BMS</deptcode><abstract>Osteoarthritis (OA) is a multifactorial disease leading to degeneration of articular cartilage, causing morbidity in approximately 8.5 million of the UK population. As the dense extracellular matrix of articular cartilage is primarily composed of collagen, cartilage repair strategies have exploited the biocompatibility and mechanical strength of bovine and porcine collagen to produce robust scaffolds for procedures such as matrix-induced chondrocyte implantation (MACI). However, mammalian sourced collagens pose safety risks such as bovine spongiform encephalopathy, transmissible spongiform encephalopathy and possible transmission of viral vectors. This study characterised a non-mammalian jellyfish (Rhizostoma pulmo) collagen as an alternative, safer source in scaffold production for clinical use. Jellyfish collagen demonstrated comparable scaffold structural properties and stability when compared to mammalian collagen. Jellyfish collagen also displayed comparable immunogenic responses (platelet and leukocyte activation/cell death) and cytokine release profile in comparison to mammalian collagen in vitro. Further histological analysis of jellyfish collagen revealed bovine chondroprogenitor cell invasion and proliferation in the scaffold structures, where the scaffold supported enhanced chondrogenesis in the presence of TGFβ1. This study highlights the potential of jellyfish collagen as a safe and biocompatible biomaterial for both OA repair and further regenerative medicine applications.</abstract><type>Journal Article</type><journal>Marine Drugs</journal><volume>19</volume><journalNumber>8</journalNumber><paginationStart>405</paginationStart><paginationEnd/><publisher>MDPI AG</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint/><issnElectronic>1660-3397</issnElectronic><keywords>osteoarthritis; articular cartilage; jellyfish collagen; MACI</keywords><publishedDay>22</publishedDay><publishedMonth>7</publishedMonth><publishedYear>2021</publishedYear><publishedDate>2021-07-22</publishedDate><doi>10.3390/md19080405</doi><url/><notes/><college>COLLEGE NANME</college><department>Biomedical Sciences</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>BMS</DepartmentCode><institution>Swansea University</institution><apcterm/><funders>This study was a collaboration between Swansea University and Jellagen Ltd through the Knowledge Economy Skills Scholarship (KESS) part funded by the European Regional Development Fund through the Welsh Government (KESS 2 c80815). This work was also supported by SMARTExpertise 2014-2020 West Wales and the Valleys, European Regional Development Fund, under Grant 2017/COL/004.</funders><projectreference/><lastEdited>2024-02-01T15:54:50.8537309</lastEdited><Created>2022-10-20T14:20:09.1826185</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Zara</firstname><surname>Ahmed</surname><order>1</order></author><author><firstname>Lydia</firstname><surname>Powell</surname><orcid>0000-0002-8641-0160</orcid><order>2</order></author><author><firstname>Navid</firstname><surname>Matin</surname><order>3</order></author><author><firstname>Andrew</firstname><surname>Mearns-Spragg</surname><orcid>0000-0003-1105-2677</orcid><order>4</order></author><author><firstname>Catherine A.</firstname><surname>Thornton</surname><order>5</order></author><author><firstname>Ilyas M.</firstname><surname>Khan</surname><order>6</order></author><author><firstname>Lewis</firstname><surname>Francis</surname><orcid>0000-0002-7803-7714</orcid><order>7</order></author></authors><documents><document><filename>61611__25714__0d401a839e684d5aa326aa30f7c16409.pdf</filename><originalFilename>61611.pdf</originalFilename><uploaded>2022-11-09T13:03:54.7556393</uploaded><type>Output</type><contentLength>3245424</contentLength><contentType>application/pdf</contentType><version>Version of Record</version><cronfaStatus>true</cronfaStatus><documentNotes>© 2021 by the authors. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language><licence>https://creativecommons.org/licenses/by/4.0/</licence></document></documents><OutputDurs/></rfc1807>
spelling	v2 61611 2022-10-20 Jellyfish Collagen: A Biocompatible Collagen Source for 3D Scaffold Fabrication and Enhanced Chondrogenicity 0e7e702952672bcbfdfd4974199202fb 0000-0002-8641-0160 Lydia Powell Lydia Powell true false 10f61f9c1248951c1a33f6a89498f37d 0000-0002-7803-7714 Lewis Francis Lewis Francis true false 2022-10-20 BMS Osteoarthritis (OA) is a multifactorial disease leading to degeneration of articular cartilage, causing morbidity in approximately 8.5 million of the UK population. As the dense extracellular matrix of articular cartilage is primarily composed of collagen, cartilage repair strategies have exploited the biocompatibility and mechanical strength of bovine and porcine collagen to produce robust scaffolds for procedures such as matrix-induced chondrocyte implantation (MACI). However, mammalian sourced collagens pose safety risks such as bovine spongiform encephalopathy, transmissible spongiform encephalopathy and possible transmission of viral vectors. This study characterised a non-mammalian jellyfish (Rhizostoma pulmo) collagen as an alternative, safer source in scaffold production for clinical use. Jellyfish collagen demonstrated comparable scaffold structural properties and stability when compared to mammalian collagen. Jellyfish collagen also displayed comparable immunogenic responses (platelet and leukocyte activation/cell death) and cytokine release profile in comparison to mammalian collagen in vitro. Further histological analysis of jellyfish collagen revealed bovine chondroprogenitor cell invasion and proliferation in the scaffold structures, where the scaffold supported enhanced chondrogenesis in the presence of TGFβ1. This study highlights the potential of jellyfish collagen as a safe and biocompatible biomaterial for both OA repair and further regenerative medicine applications. Journal Article Marine Drugs 19 8 405 MDPI AG 1660-3397 osteoarthritis; articular cartilage; jellyfish collagen; MACI 22 7 2021 2021-07-22 10.3390/md19080405 COLLEGE NANME Biomedical Sciences COLLEGE CODE BMS Swansea University This study was a collaboration between Swansea University and Jellagen Ltd through the Knowledge Economy Skills Scholarship (KESS) part funded by the European Regional Development Fund through the Welsh Government (KESS 2 c80815). This work was also supported by SMARTExpertise 2014-2020 West Wales and the Valleys, European Regional Development Fund, under Grant 2017/COL/004. 2024-02-01T15:54:50.8537309 2022-10-20T14:20:09.1826185 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Zara Ahmed 1 Lydia Powell 0000-0002-8641-0160 2 Navid Matin 3 Andrew Mearns-Spragg 0000-0003-1105-2677 4 Catherine A. Thornton 5 Ilyas M. Khan 6 Lewis Francis 0000-0002-7803-7714 7 61611__25714__0d401a839e684d5aa326aa30f7c16409.pdf 61611.pdf 2022-11-09T13:03:54.7556393 Output 3245424 application/pdf Version of Record true © 2021 by the authors. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license true eng https://creativecommons.org/licenses/by/4.0/
title	Jellyfish Collagen: A Biocompatible Collagen Source for 3D Scaffold Fabrication and Enhanced Chondrogenicity
spellingShingle	Jellyfish Collagen: A Biocompatible Collagen Source for 3D Scaffold Fabrication and Enhanced Chondrogenicity Lydia Powell Lewis Francis
title_short	Jellyfish Collagen: A Biocompatible Collagen Source for 3D Scaffold Fabrication and Enhanced Chondrogenicity
title_full	Jellyfish Collagen: A Biocompatible Collagen Source for 3D Scaffold Fabrication and Enhanced Chondrogenicity
title_fullStr	Jellyfish Collagen: A Biocompatible Collagen Source for 3D Scaffold Fabrication and Enhanced Chondrogenicity
title_full_unstemmed	Jellyfish Collagen: A Biocompatible Collagen Source for 3D Scaffold Fabrication and Enhanced Chondrogenicity
title_sort	Jellyfish Collagen: A Biocompatible Collagen Source for 3D Scaffold Fabrication and Enhanced Chondrogenicity
author_id_str_mv	0e7e702952672bcbfdfd4974199202fb 10f61f9c1248951c1a33f6a89498f37d
author_id_fullname_str_mv	0e7e702952672bcbfdfd4974199202fb_*_Lydia Powell 10f61f9c1248951c1a33f6a89498f37d_*_Lewis Francis
author	Lydia Powell Lewis Francis
author2	Zara Ahmed Lydia Powell Navid Matin Andrew Mearns-Spragg Catherine A. Thornton Ilyas M. Khan Lewis Francis
format	Journal article
container_title	Marine Drugs
container_volume	19
container_issue	8
container_start_page	405
publishDate	2021
institution	Swansea University
issn	1660-3397
doi_str_mv	10.3390/md19080405
publisher	MDPI AG
college_str	Faculty of Medicine, Health and Life Sciences
hierarchytype
hierarchy_top_id	facultyofmedicinehealthandlifesciences
hierarchy_top_title	Faculty of Medicine, Health and Life Sciences
hierarchy_parent_id	facultyofmedicinehealthandlifesciences
hierarchy_parent_title	Faculty of Medicine, Health and Life Sciences
department_str	Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine
document_store_str	1
active_str	0
description	Osteoarthritis (OA) is a multifactorial disease leading to degeneration of articular cartilage, causing morbidity in approximately 8.5 million of the UK population. As the dense extracellular matrix of articular cartilage is primarily composed of collagen, cartilage repair strategies have exploited the biocompatibility and mechanical strength of bovine and porcine collagen to produce robust scaffolds for procedures such as matrix-induced chondrocyte implantation (MACI). However, mammalian sourced collagens pose safety risks such as bovine spongiform encephalopathy, transmissible spongiform encephalopathy and possible transmission of viral vectors. This study characterised a non-mammalian jellyfish (Rhizostoma pulmo) collagen as an alternative, safer source in scaffold production for clinical use. Jellyfish collagen demonstrated comparable scaffold structural properties and stability when compared to mammalian collagen. Jellyfish collagen also displayed comparable immunogenic responses (platelet and leukocyte activation/cell death) and cytokine release profile in comparison to mammalian collagen in vitro. Further histological analysis of jellyfish collagen revealed bovine chondroprogenitor cell invasion and proliferation in the scaffold structures, where the scaffold supported enhanced chondrogenesis in the presence of TGFβ1. This study highlights the potential of jellyfish collagen as a safe and biocompatible biomaterial for both OA repair and further regenerative medicine applications.
published_date	2021-07-22T15:54:51Z
_version_	1789712548658937856
score	11.012678

Jellyfish Collagen: A Biocompatible Collagen Source for 3D Scaffold Fabrication and Enhanced Chondrogenicity

Similar Items